Eli Lilly is on track to apply for FDA approval by late 2025, the drugmaker announced
Hardeland R et al
Practically all studies seem to confirm that the deficiency of carnitine in plasma levels at short term is not associated with clinically relevant symptoms in those patients presenting it: neither lower weight gain nor hypertriglyceridemia or shorter hospital stay
Gould says
However, restarting the medication is not recommended if you are nursing
Notably, most clinical investigations studied women (1404 female versus 83 male participants), which is expected since estrogen declines after age 30 years, and further estrogen decline with aging represents health challenges, as well as a reduction in QOL [9, 10, 19,20,21,22] and a degradation in the most visible organ of the bodythe skin [9, 10]